A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Emicizumab in Healthy Chinese Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Hemophilia A
Related studies linked through entity extraction aliases.
Exercise Versus DDAVP in Patients With Mild Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE4
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of BAX 888 in Male Adults With Severe Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
BAY94-9027 PK Study Comparing to Another Long Acting Product
- Status
- COMPLETED
- Phase
- PHASE1
Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures
- Status
- TERMINATED
- Phase
- PHASE4
Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq
- Status
- TERMINATED
- Phase
- N/A
World Bleeding Disorders Registry
- Status
- RECRUITING
- Phase
- N/A
Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of a Standardized Protocol for Thrombin Generation Assay
- Status
- COMPLETED
- Phase
- N/A
Comparison of Ideal vs. Actual Weight Base Factor Dosing
- Status
- UNKNOWN
- Phase
- NA
Understanding Hemophilia A and B Drug Dosage Administration Patterns
- Status
- TERMINATED
- Phase
- N/A
Lentiviral FVIII Gene Therapy
- Status
- RECRUITING
- Phase
- PHASE1
A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
INdividualized ITI Based on Fviii(ATE) Protection by VWF
- Status
- TERMINATED
- Phase
- PHASE4
A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia
- Status
- COMPLETED
- Phase
- N/A
ADYNOVATE Drug Use-Results Survey
- Status
- COMPLETED
- Phase
- N/A
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies
- Status
- COMPLETED
- Phase
- PHASE4